论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Wang Q, Zhang P, Zhao D, Jiang Y, Zhao F, Wang Y, Li X, Du X, Yu Y
Received 9 July 2018
Accepted for publication 21 September 2018
Published 13 November 2018 Volume 2018:11 Pages 2241—2248
DOI https://doi.org/10.2147/IDR.S179618
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Professor Suresh Antony
Objective: Here, we
report a case of severe infection caused by Escherichia coli that
harbored mcr-1 , bla NDM-5, and acquired
resistance to tigecycline during tigecycline salvage therapy.
Methods: Antimicrobial
susceptibility testing, Southern blot hybridization, and complete genome
sequence of the strains were carried out. The genetic characteristics of
the mcr-1 and bla NDM-5 plasmids were
analyzed. The whole genome sequencing of mcr-1 -containing
plasmid was completed. Finally, putative single nucleotide polymorphisms and
deletion mutations in the tigecycline-resistant strain were predicted.
Results: Three E. coli isolates
were obtained from ascites, pleural effusion, and stool of a patient; they were
resistant to almost all the tested antibiotics. The first two strains separated
from ascites (E-FQ) and hydrothorax (E-XS) were susceptible to amikacin and
tigecycline; however, the third strain from stool (E-DB) was resistant to
tigecycline after nearly 3 weeks’ treatment with tigecycline. All three
isolates possessed both mcr-1 and bla NDM-5. The bla NDM-5 gene was
found on the IncX3 plasmid, whereas the mcr-1 , fosA3 and bla CTX-M-14 were
located on the IncHI2 plasmid. Mutations in acrB and lon were the
reason for the resistance to tigecycline.
Conclusion: This is
the first report of a colistin-, carbapenem-, and tigecycline-resistant E. coli in China.
Tigecycline resistance acquired during tigecycline therapy is of great concern
for us because tigecycline is a drug of last resort to treat
carbapenem-resistant Gram-negative bacterial infections. Furthermore, the
transmission of such extensively drug-resistant isolates may pose a great
threat to public health.
Keywords: mcr-1 , bla NDM-5,
tigecycline-resistance, acrB , lon